• 1
    Law M, Morris JK, Wald N, Luczynska C, Burney P. Changes in atopy over a quarter of a century, based on cross sectional data at three time periods. BMJ 2005;330:11871188.
  • 2
    Jarvis D, Luczynska C, Chinn S, Potts J, Sunyer J, Janson C et al. Change in prevalence of IgE sensitization and mean total IgE with age and cohort. J Allergy Clin Immunol 2005;116:675682.
  • 3
    Linneberg A, Gislum M, Johansen N, Husemoen LL, Jorgensen T. Temporal trends of aeroallergen sensitization over twenty-five years. Clin Exp Allergy 2007;37:11371142.
  • 4
    Douwes J, Pearce N. Asthma and the westernization ‘package’. Int J Epidemiol 2002;31:10981102.
  • 5
    Krause T, Koch A, Friborg J, Poulsen LK, Kristensen B, Melbye M. Frequency of atopy in the Arctic in 1987 and 1998. Lancet 2002;360:691692.
  • 6
    Nicolaou N, Siddique N, Custovic A. Allergic disease in urban and rural populations: increasing prevalence with increasing urbanization. Allergy 2005;60:13571360.
  • 7
    Von Hertzen LC, Haahtela T. Asthma and atopy – the price of affluence? Allergy 2004;59:124137.
  • 8
    Schaub B, Von Mutius E. Obesity and asthma, what are the links? Curr Opin Allergy Clin Immunol 2005;5:185193.
  • 9
    Ford ES. The epidemiology of obesity and asthma. J Allergy Clin Immunol 2005;115:897909.
  • 10
    Huovinen E, Kaprio J, Koskenvuo M. Factors associated to lifestyle and risk of adult onset asthma. Respir Med 2003;97:273280.
  • 11
    Romieu I, Trenga C. Diet and obstructive lung diseases. Epidemiol Rev 2001;23:268287.
  • 12
    Svanes C, Real FG, Gislason T, Jansson C, Jogi R, Norrman E et al. Association of asthma and hay fever with irregular menstruation. Thorax 2005;60:445450.
  • 13
    Forbes L. Asthma and atopy: endocrine or metabolic conditions? Thorax 2005;60:793794.
  • 14
    Al Shawwa BA, Al Huniti NH, DeMattia L, Gershan W. Asthma and insulin resistance in morbidly obese children and adolescents. J Asthma 2007;44:469473.
  • 15
    Jousilahti P, Salomaa V, Hakala K, Rasi V, Vahtera E, Palosuo T. The association of sensitive systemic inflammation markers with bronchial asthma. Ann Allergy Asthma Immunol 2002;89:381385.
  • 16
    Ford ES. Asthma, body mass index, and C-reactive protein among US adults. J Asthma 2003;40:733739.
  • 17
    Hersoug LG, Linneberg A. The link between the epidemics of obesity and allergic diseases: does obesity induce decreased immune tolerance? Allergy 2007;62:12051213.
  • 18
    Jorgensen T, Borch-Johnsen K, Thomsen TF, Ibsen H, Glumer C, Pisinger C. A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99. Eur J Cardiovasc Prev Rehabil 2003;10:377386.
  • 19
    Linneberg A, Husemoen LL, Nielsen NH, Madsen F, Frolund L, Johansen N. Screening for allergic respiratory disease in the general population with the ADVIA Centaur Allergy Screen Assay. Allergy 2006;61:344348.
  • 20
    Albareda M, Rodriguez-Espinosa J, Murugo M, De Leiva A, Corcoy R. Assessment of insulin sensitivity and beta-cell function from measurements in the fasting state and during an oral glucose tolerance test. Diabetologia 2000;43:15071511.
  • 21
    Tripathy D, Carlsson M, Almgren P, Isomaa B, Taskinen MR, Tuomi T et al. Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia Study. Diabetes 2000;49:975980.
  • 22
    World Health Organisation. Definition diagnosis and classification of diabetes mellitus and its complications. Report of a WHO Consultation, Part 1: Diagnosis and classification of diabetes mellitus. Geneva: World Health Organisation, 1999.
  • 23
    World Health Orginazation. Report of a WHO consultation. Obesity: preventing and managing the global epidemic. Geneva: World Health Orginazation, 2004.
  • 24
    Ronmark E, Andersson C, Nystrom L, Forsberg B, Jarvholm B, Lundback B. Obesity increases the risk of incident asthma among adults. Eur Respir J 2005;25:282288.
  • 25
    Kronander UN, Falkenberg M, Zetterstrom O. Prevalence and incidence of asthma related to waist circumference and BMI in a Swedish community sample. Respir Med 2004;98:11081116.
  • 26
    Appleton SL, Adams RJ, Wilson DH, Taylor AW, Ruffin RE. Central obesity is associated with nonatopic but not atopic asthma in a representative population sample. J Allergy Clin Immunol 2006;118:12841291.
  • 27
    Knoflach M, Kiechl S, Mayr A, Willeit J, Poewe W, Wick G. Allergic rhinitis, asthma, and atherosclerosis in the Bruneck and ARMY studies. Arch Intern Med 2005;165:25212526.
  • 28
    Hospers JJ, Rijcken B, Schouten JP, Postma DS, Weiss ST. Eosinophilia and positive skin tests predict cardiovascular mortality in a general population sample followed for 30 years. Am J Epidemiol 1999;150:482491.
  • 29
    Brunekreef B, Hoek G, Fischer P, Spieksma FT. Relation between airborne pollen concentrations and daily cardiovascular and respiratory-disease mortality. Lancet 2000;355:15171518.
  • 30
    Schroeder EB, Welch VL, Couper D, Nieto FJ, Liao D, Rosamond WD et al. Lung function and incident coronary heart disease: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 2003;158:11711181.
  • 31
    Iribarren C, Tolstykh IV, Eisner MD. Are patients with asthma at increased risk of coronary heart disease? Int J Epidemiol 2004;33:743748.
  • 32
    Rodriguez-Moran M, Guerrero-Romero F. Increased levels of C-reactive protein in noncontrolled type II diabetic subjects. J Diabetes Complicat 1999;13:211215.
  • 33
    Lowe GD. Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease. J Thromb Haemost 2005;3:16181627.
  • 34
    Schachter LM, Salome CM, Peat JK, Woolcock AJ. Obesity is a risk for asthma and wheeze but not airway hyperresponsiveness. Thorax 2001;56:48.
  • 35
    Sin DD, Jones RL, Man SF. Obesity is a risk factor for dyspnea but not for airflow obstruction. Arch Intern Med 2002;162:14771481.